DK0974366T3
(da)
|
1997-03-28 |
2007-01-29 |
Eisai Co Ltd |
Orale, farmaceutiske præparater med nedsat bitterhed ved maskering
|
JP4083818B2
(ja)
|
1997-06-06 |
2008-04-30 |
ディポメド,インコーポレイティド |
高度可溶性薬物の制御された放出のための胃滞留性の経口薬物投与形
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
FR2775188B1
(fr)
*
|
1998-02-23 |
2001-03-09 |
Lipha |
Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
|
CN1203846C
(zh)
*
|
1998-03-19 |
2005-06-01 |
布里斯托尔-迈尔斯斯奎布公司 |
高溶解性药物的双相控释递送系统和方法
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US20040259895A1
(en)
*
|
1998-05-28 |
2004-12-23 |
Medical Research Institute |
Oral formulation of lipid soluble thiamine and lipoic acid
|
US6197340B1
(en)
*
|
1998-05-28 |
2001-03-06 |
Medical Research Institute |
Controlled release lipoic acid
|
DE19823831A1
(de)
*
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
US6117451A
(en)
*
|
1998-08-25 |
2000-09-12 |
Pharmalogix, Inc. |
Direct compression metformin hydrochloride tablets
|
EP1025858A4
(en)
*
|
1998-08-28 |
2009-03-11 |
Eisai R&D Man Co Ltd |
DRUGS WITH REDUCED BITTERNESS ETC.
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6194466B1
(en)
*
|
1998-10-15 |
2001-02-27 |
Elizabeth Marie Cottingham |
Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
|
AP1692A
(en)
*
|
1998-11-12 |
2006-12-12 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
|
CZ20011629A3
(cs)
*
|
1998-11-12 |
2001-12-12 |
Smithkline Beecham Plc |
Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
|
US20030153607A1
(en)
*
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
US20040081697A1
(en)
*
|
1998-11-12 |
2004-04-29 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
AR023700A1
(es)
*
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
US6878749B2
(en)
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
AU767812B2
(en)
|
2000-02-04 |
2003-11-27 |
Depomed, Inc. |
Shell-and-core dosage form approaching zero-order drug release
|
ATE437632T1
(de)
*
|
2000-03-01 |
2009-08-15 |
Eisai R&D Man Co Ltd |
Schnellzerfallende polyvinylhaltige tablette
|
US7858119B1
(en)
|
2000-05-09 |
2010-12-28 |
Amina Odidi |
Extended release pharmaceuticals
|
US6676966B1
(en)
*
|
2000-05-09 |
2004-01-13 |
Intellipharmaceutics Corp. |
Extended release metformin hydrochloride formulations
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
EP1322158B1
(en)
*
|
2000-10-02 |
2012-08-08 |
USV Ltd. |
Sustained release pharmaceutical compositions containing metformin and method of their production
|
US6451808B1
(en)
|
2000-10-17 |
2002-09-17 |
Depomed, Inc. |
Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6790459B1
(en)
*
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
AU2002230830A1
(en)
|
2000-11-03 |
2002-05-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
US6524618B1
(en)
|
2001-06-12 |
2003-02-25 |
Vijai Kumar |
Directly compressible extended-release matrix formulation for metformin hydrochloride
|
US20030021841A1
(en)
*
|
2001-07-02 |
2003-01-30 |
Matharu Amol Singh |
Pharmaceutical composition
|
JP2005508331A
(ja)
*
|
2001-09-28 |
2005-03-31 |
サン・ファーマシューティカル・インダストリーズ・リミテッド |
糖尿病の処置のための投与製剤
|
IN192180B
(es)
*
|
2001-09-28 |
2004-03-06 |
Ranbaxy Lab |
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
CN1700910A
(zh)
*
|
2001-11-06 |
2005-11-23 |
兰贝克赛实验室有限公司 |
甲福明控释片剂
|
US20030118647A1
(en)
*
|
2001-12-04 |
2003-06-26 |
Pawan Seth |
Extended release tablet of metformin
|
DK1482919T3
(da)
*
|
2002-01-25 |
2007-07-30 |
Silanes Sa De Cv Lab |
Farmaceutisk sammensætning til blodsukkerkontrol hos patienter med type 2 diabetes
|
US20030187074A1
(en)
*
|
2002-03-04 |
2003-10-02 |
Javed Hussain |
Oral compositions for treatment of diabetes
|
CN100553625C
(zh)
|
2002-04-09 |
2009-10-28 |
弗拉梅技术公司 |
活性成分微囊的口服混悬液
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
US20030224046A1
(en)
*
|
2002-06-03 |
2003-12-04 |
Vinay Rao |
Unit-dose combination composition for the simultaneous delivery of a short-acting and a long-acting oral hypoglycemic agent
|
KR100897890B1
(ko)
|
2002-06-17 |
2009-05-18 |
인벤티아 헬스케어 피브이티. 엘티디. |
티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법
|
AR040682A1
(es)
|
2002-07-25 |
2005-04-13 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
CA2494281A1
(en)
|
2002-08-02 |
2004-02-12 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
US9060941B2
(en)
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
KR20100137023A
(ko)
|
2002-09-20 |
2010-12-29 |
안드렉스 랩스 엘엘씨 |
약제학적 정제
|
US7785627B2
(en)
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
*
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US8084058B2
(en)
*
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
EP1646374A1
(en)
*
|
2003-06-16 |
2006-04-19 |
Ranbaxy Laboratories, Ltd. |
Extended-release tablets of metformin
|
CA2529984C
(en)
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
US20050084531A1
(en)
*
|
2003-10-16 |
2005-04-21 |
Jatin Desai |
Tablet with aqueous-based sustained release coating
|
EP1591114A1
(en)
*
|
2004-03-12 |
2005-11-02 |
Fournier Laboratories Ireland Limited |
Use of metformin and orlistat for the treatment or prevention of obesity
|
KR100772980B1
(ko)
*
|
2004-04-01 |
2007-11-02 |
한미약품 주식회사 |
메트포르민의 경구투여용 서방성 제제
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
EP2135602A1
(en)
*
|
2004-08-13 |
2009-12-23 |
Boehringer Ingelheim International GmbH |
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
EP1814528A2
(en)
*
|
2004-10-08 |
2007-08-08 |
Rubicon Research Private Limited |
Process for making a highly compressible controlled delivery compositions of metformin
|
US20060121108A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Prasad C K |
System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride
|
SI1878426T1
(sl)
*
|
2005-04-26 |
2010-09-30 |
Dainippon Sumitomo Pharma Co |
Granulatni pripravek ki vsebuje bigvanidno spojino
|
KR100780553B1
(ko)
*
|
2005-08-18 |
2007-11-29 |
한올제약주식회사 |
메트포르민 서방정 및 그의 제조방법
|
MXPA05009633A
(es)
*
|
2005-09-08 |
2007-03-07 |
Silanes Sa De Cv Lab |
Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
JP5457830B2
(ja)
|
2006-04-03 |
2014-04-02 |
オディディ,イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
KR100791844B1
(ko)
*
|
2006-06-30 |
2008-01-07 |
주식회사유한양행 |
메트포르민 또는 그의 염을 함유하는 서방성 제제 및 그의제조방법
|
KR20080009016A
(ko)
*
|
2006-07-21 |
2008-01-24 |
주식회사 한독약품 |
위 체류형 펠렛 및 이의 제조방법
|
US8778398B2
(en)
|
2008-11-04 |
2014-07-15 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
NZ623838A
(en)
|
2009-04-16 |
2015-09-25 |
Taisho Pharmaceutical Co Ltd |
Pharmaceutical compositions for the treatment of diabetes mellitus
|
CA2780939C
(en)
|
2009-11-13 |
2018-06-12 |
Bristol-Myers Squibb Company |
Bilayer tablet formulations
|
AU2010319377B2
(en)
|
2009-11-13 |
2014-10-23 |
Astrazeneca Ab |
Immediate release tablet formulations
|
MX2020011961A
(es)
|
2010-03-24 |
2022-04-19 |
Jazz Pharmaceuticals Inc |
Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
|
US8581001B2
(en)
|
2010-04-16 |
2013-11-12 |
Codman & Shurtleff |
Metformin-cysteine prodrug
|
RU2465896C2
(ru)
*
|
2011-01-20 |
2012-11-10 |
Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") |
Фармацевтическая противодиабетическая композиция пролонгированного действия
|
MX2012014070A
(es)
*
|
2012-12-03 |
2014-06-23 |
Landsteiner Scient S A De C V |
Composiciones metformina-orlistat.
|
JP2017514903A
(ja)
*
|
2014-05-01 |
2017-06-08 |
サン ファーマシューティカル インダストリーズ リミテッドSun Pharmaceutical Industries Ltd. |
徐放性懸濁組成物
|
US20180104197A9
(en)
|
2014-05-01 |
2018-04-19 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of metformin
|
US10258583B2
(en)
|
2014-05-01 |
2019-04-16 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of guanfacine
|
WO2015166472A1
(en)
*
|
2014-05-01 |
2015-11-05 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of metformin
|
US9962336B2
(en)
|
2014-05-01 |
2018-05-08 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
US10166246B2
(en)
|
2014-05-27 |
2019-01-01 |
City Of Hope |
TGR5 agonist complexes for treating diabetes and cancer
|
US10285908B2
(en)
|
2014-07-30 |
2019-05-14 |
Sun Pharmaceutical Industries Ltd |
Dual-chamber pack
|
US10398662B1
(en)
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
US10238803B2
(en)
|
2016-05-02 |
2019-03-26 |
Sun Pharmaceutical Industries Limited |
Drug delivery device for pharmaceutical compositions
|
US11602513B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
US11602512B1
(en)
|
2016-07-22 |
2023-03-14 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
UY37341A
(es)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
|
US11986451B1
(en)
|
2016-07-22 |
2024-05-21 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
US11504347B1
(en)
|
2016-07-22 |
2022-11-22 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
US20190365785A1
(en)
*
|
2017-02-22 |
2019-12-05 |
Children's Hospital Medical Center |
Inhibition of unfolded protein response for suppressing or preventing allergic reaction to food
|
US20180263936A1
(en)
|
2017-03-17 |
2018-09-20 |
Jazz Pharmaceuticals Ireland Limited |
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
|
CN108451923A
(zh)
*
|
2018-05-31 |
2018-08-28 |
常州兰陵制药有限公司 |
盐酸二甲双胍速释胶囊及其制备方法
|
CA3115122A1
(en)
|
2018-11-19 |
2020-05-28 |
Jazz Pharmaceuticals Ireland Limited |
Alcohol-resistant drug formulations
|
CN113473980A
(zh)
|
2019-03-01 |
2021-10-01 |
弗拉梅尔爱尔兰有限公司 |
在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
|
US11583510B1
(en)
|
2022-02-07 |
2023-02-21 |
Flamel Ireland Limited |
Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
|
US11779557B1
(en)
|
2022-02-07 |
2023-10-10 |
Flamel Ireland Limited |
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|